Yutaro Kaneko Selected Research

Premedication

4/2017

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yutaro Kaneko Research Topics

Disease

7	Neoplasms (Cancer) 06/2021 - 11/2006
4	Atrial Fibrillation 02/2023 - 04/2021
3	Malignant Mesothelioma 06/2021 - 10/2018
2	Weight Loss (Weight Reduction) 12/2022 - 01/2022
2	COVID-19 01/2022 - 01/2022
2	Neuroblastoma 11/2008 - 09/2007
2	Neuroectodermal Tumors (Neuroectodermal Tumor) 11/2008 - 09/2007
1	Diabetes Mellitus 02/2023
1	Leukemia 12/2022
1	Bronchiolitis Obliterans Syndrome 12/2022
1	Ventricular Tachycardia 09/2022
1	Myocardial Infarction 09/2022
1	Heart Failure 05/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Thrombosis (Thrombus) 04/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Immune System Diseases (Immune Disorders) 01/2018
1	Hypersensitivity (Allergy) 04/2017
1	Melanoma (Melanoma, Malignant) 11/2008
1	Infections 01/2007
1	Vaccinia 01/2007

Drug/Important Bio-Agent (IBA)

6	Monoclonal AntibodiesIBA 12/2022 - 04/2017
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2021
2	Glycoproteins (Glycoprotein)IBA 11/2019 - 11/2008
2	VaccinesIBA 11/2008 - 09/2007
2	CarbohydratesIBA 11/2008 - 09/2007
2	GD2 gangliosideIBA 11/2008 - 09/2007
1	Oxygen (Dioxygen)IBA 02/2023
1	Therapeutic UsesIBA 12/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	Interferon Type IIBA 01/2022
1	NivolumabIBA 06/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2019
1	Ubiquitin-Specific ProteasesIBA 10/2018
1	CollagenIBA 11/2008
1	Polysaccharides (Glycans)IBA 11/2008
1	Peptide LibraryIBA 11/2008
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 11/2008
1	EpitopesIBA 11/2008
1	Cell Adhesion MoleculesIBA 11/2008
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2008
1	Immunoglobulin M (IgM)IBA 09/2007
1	interleukin-21 (interleukin 21)IBA 09/2007
1	CytokinesIBA 09/2007
1	Interleukin-15 (Interleukin 15)IBA 09/2007
1	AntigensIBA 09/2007
1	beta-Galactosidase (Lactaid)IBA 01/2007
1	Liposomes (Liposome)IBA 01/2007
1	2,2,2-trifluoroethane sulfonyl-monomethoxypolyethylene glycolIBA 01/2007
1	MMEIBA 11/2006
1	LentinanIBA 11/2006
1	Complement System Proteins (Complement)IBA 11/2006
1	micellapistIBA 11/2006

Therapy/Procedure

3	Therapeutics 12/2022 - 01/2018
2	Catheter Ablation 09/2022 - 01/2022
1	Deep Sedation 02/2023
1	Lasers (Laser) 01/2023
1	Cardiac Resynchronization Therapy 05/2022
1	Cardiac Resynchronization Therapy Devices 05/2022
1	Punctures 04/2021
1	Premedication 04/2017
1	Immunotherapy 09/2007